ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
3 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
American Society for Blood and Marrow Transplantation New Investigator Awards
Submission Deadline: October 1, 2014
The ASBMT New Investigator Awards are designed to encourage clinical or laboratory research by young investigators in the field of blood and marrow transplantation. The award, $30,000 per year for two years, preferably is to be used to support the investigator’s salary for his or her research effort. Alternatively, the award may be used for direct support of research costs.
To be eligible for consideration for a New Investigator Award, an applicant must be a fellow-in-training or junior-level faculty (an instructor or assistant professor no more than three years past a post-doctoral program or a clinical research fellowship).
Applicants with other significant new investigator funding from peer-reviewed extramural sources may be less competitive than those without such funding. Institutional startup funds for junior faculty are not considered peer-reviewed or extramural.
Applicants are encouraged, but not required, to be an ASBMT member. An applicant must have a sponsor who is an ASBMT member. The sponsor serves as a mentor for the applicant’s research and career development.
Applicants are required to submit the New Investigator Awards application, a curriculum vitae that adheres to the NIH biographical sketch format, a list of Other Support that also adheres to the NIH format, a letter of recommendation from the sponsor/mentor (maximum two pages), and a description of the proposed research that must not exceed four pages.
Judging and Evaluation Criteria
The review committee is chaired by a member of the ASBMT Board of Directors, appointed by the ASBMT President with Board approval. The Chair then appoints review committee members ad hoc, after approval of the ASBMT President but based on the expertise required to review the topics covered by the applications.
New Investigator Award applications will be evaluated for (a) scientific merit within the field of blood and marrow transplantation, (b) significance and anticipated overall impact of the potential findings, (c) institutional environment, (d) the training record of the sponsor/mentor, and (e) the potential contribution of the proposed research to the field of blood and marrow transplantation. As these are “new” investigator awards, less emphasis is placed on preliminary data.
The number of award(s) that can be made varies from year to year, depending on available funding.
Unfortunately, due to the additional work that would be required of reviewers and the short time lines involved, applicants will not receive written critiques after review.
The award winner(s) will be notified around late November or early December, in time to make arrangements to attend the 2015 BMT Tandem Meetings, February 11-15, 2015, in San Diego, California. The award(s) will be publicly announced at this meeting. The award will be activated July 1, 2015.
The award will be $30,000 for the first year, renewable for an additional $30,000 for a second year, contingent upon a report of satisfactory progress.
American Society of Hematology Scholar Awards
The ASH Scholar Awards are designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.
Awards are limited to a maximum of $100,000 for fellow scholars and $150,000 for junior faculty scholars over a two- to three-year period, with an annual maximum of $50,000 for fellows and $75,000 for junior faculty. Up to 15 percent of the award can be (but is not required to be) used for benefits, including medical and dental insurance, life insurance, and retirement benefits.
All awards are activated on July 1 of the following year. The applicant has the option of concluding the award on June 30, two or three years after activation. All award payments are made on a quarterly basis - the amount depends on whether the award is being spread over two or three years. Payments are made to the appropriate financial officer of the institution as indicated on the proposed budget within the full application.
ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, cells and animals, as well as samples obtained from humans, all of which are designed to further our understanding of the blood, bone marrow, and related organs or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials. The proposal should address clinical applications - not just test development - although the development of novel instrumentation of value to hematology is clearly within the scope of the application. Clinical trial projects with laboratory correlatives are considered clinical.
Clinical Research: ASH considers clinical/translational research to include patient-oriented research and outcomes-based research. ASH emphasizes that clinical research must involve substantial interaction with patients.
For the purposes of the ASH Scholar Awards program, patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
ASH strongly encourages applications in outcomes-based research. Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.
Applications that fall within any of the categories discussed above are encouraged.
Letter of Intent Due: Wednesday, May 7, 2014
Application Made Available for Those Who Successfully Submit a LOI by the Deadline: Thursday, June 5, 2014
Application Deadline Friday, August 1, 2014
Award Winners Notified: Mid-November, 2014
Activation of Award: Wednesday, July 1, 2015
These eligibility requirements are evaluated as of the date of the LOI submission.
Eligible applicants must be a citizen of the United States or Canada or hold a visa in the United States or Canada.
Eligible applicants must conduct research within the US or Canada
Scholar Award applicants are required to be members of ASH in good standing at the time of the Letter of Intent submission, and for the duration of the Scholar Award Program. If your membership application is pending at the time of the Scholar Award application deadline, you will still be considered for a Scholar Award.
To verify your membership status, please log on to the membership section of the ASH website. If you need assistance with your username and password, please contact an ASH Customer Relations Representative at email@example.com.
Fellow Scholar Awards
PhD or MD/PhD applicants must have fewer than 5 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants should have more than 3 but fewer than 5 years of research experience (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants with fewer than 3 years research experience (inclusive of fellowship research time) should consider applying for the Senior RTAF award
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience
Junior Faculty Scholar Awards
MD, PhD or MD/PhD applicants must have more than 5 but fewer than 10 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience.
Aniara Coagulation Research Grant
The Aniara Coagulation Research Grant provides $10,000.00 for "established" investigators (e.g., faculty at an academic institution) and for "students / trainees", to do innovative coagulation/hematology research. Deadline for receipt of application is Oct 31, 2014.
The Aniara research panel awards one yearly $10,000.00 grant for specialized coagulation/hematology research. All proposed projects must be in the coagulation/hematology scientific field of interest.
Funding is restricted to North America, South America, and Latin America, Swedish, Danish, Finnish, Norwegian, Estonian, Latvian, Lithuanian, and Icelandic citizens. This grant program does not pay educational tuition, nor does it offer scholarships or fellowships of any kind.
Applicants are expected to have advanced degrees (Ph.D. or equivalent) and be associated with an educational organization or institution. Independent researchers or those pursuing a Ph.D.-level degree may apply, but awards to non-PhD. applicants are rare. As a general rule, all applicants are expected to have published a minimum of three articles in peer-reviewed scientific journals.
ANIARA will award one $10,000.00 grant recipient per year.
Aniara Coagulation research grants may not be used for indirect costs, overhead, and other expenses not directly related to the project. Fringe benefits are also excluded, as are salaries.
Funds may not be used for travel to scientific/professional meetings or conferences, legal actions, land acquisition, endowments, construction of permanent field stations, or publishing research results.